Magnetic Resonance Imaging of Breast Cancer

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT01035112
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
21 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • MRI — PROCEDURE

Study Details

To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.

Key Dates

Start date
Apr 1, 1995
Status verified
Jun 2025
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
500 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Magnetic Resonance Imaging (MRI) of Breast Cancer
    Contrast-enhanced magnetic resonance imaging (MRI) using the standard department of Radiology MRI screening procedures. The duration of scanning may be variable, but will not exceed 90 minutes.

Primary Outcome Measure

To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer. [ Time Frame: Length of one MRI scan ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicineStanfordCalifornia94305
Jocelyn Steffen
[email protected]
650-725-1812
Bruce Lewis Daniel (PRINCIPAL_INVESTIGATOR)
Brian Andrew Hargreaves (SUB_INVESTIGATOR)
Robert J Herfkens (SUB_INVESTIGATOR)

Find similar trials in Stanford, CA

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Stanford University School of Medicine· Stanford, CA

Related Studies